Apte, A., Koren, E., Koshkaryev, A., & Torchilin, V. P. (2014). Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models. Landes Bioscience.
Citação norma ChicagoApte, Anjali, Erez Koren, Alexander Koshkaryev, and Vladimir P. Torchilin. Doxorubicin in TAT Peptide-modified Multifunctional Immunoliposomes Demonstrates Increased Activity against Both Drug-sensitive and Drug-resistant Ovarian Cancer Models. Landes Bioscience, 2014.
MLA CitationApte, Anjali, Erez Koren, Alexander Koshkaryev, and Vladimir P. Torchilin. Doxorubicin in TAT Peptide-modified Multifunctional Immunoliposomes Demonstrates Increased Activity against Both Drug-sensitive and Drug-resistant Ovarian Cancer Models. Landes Bioscience, 2014.